Announcements | Pfizer Medical Information

Medical Information

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

I am a U.S. Healthcare ProfessionalYes, I am a U.S. Healthcare Professional

I am a U.S. Patient / CaregiverNo, go back to the patient portal

Announcement	Date
Pfizer’s ELREXFIO™ Receives U.S. FDA Accelerated Approval for Relapsed or Refractory Multiple Myeloma	August 14, 2023
Paxlovid Receives FDA Approval for Adult Patients at High Risk of Progression to Severe COVID-19.	May 25, 2023

All announcements